Value of Mismatch Repair, <i>KRAS</i> , and <i>BRAF</i> Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer - Concepedia

Concepedia

Publication | Open Access

Value of Mismatch Repair, <i>KRAS</i> , and <i>BRAF</i> Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer

DOI Full Paper Access

675

Citations

31

References

2011

Year

Gordon Hutchins, Katie Southward, Kelly Handley, Laura Magill, Claire Beaumont, Jens Stahlschmidt, Susan D. Richman, Philip Chambers, David Kerr, Richard Gray,

Journal of Clinical Oncology

Abstract

MMR assays identify patients with a low risk of recurrence. KRAS mutational analysis provides useful additional risk stratification to guide use of chemotherapy.

References

	Year	Citations

Page 1